Literature DB >> 17316584

Structural analysis of mucoidan, an acidic extracellular polysaccharide produced by a pristane-assimilating marine bacterium, Rhodococcus erythropolis PR4.

Makoto Urai1, Hiroshi Yoshizaki, Hirosi Anzai, Jun Ogihara, Noriyuki Iwabuchi, Shigeaki Harayama, Michio Sunairi, Mutsuyasu Nakajima.   

Abstract

Rhodococcus erythropolis PR4 is a marine bacterium that can degrade various alkanes including pristane, a C(19) branched alkane. This strain produces a large quantity of extracellular polysaccharides (EPS), which are assumed to play an important role in the hydrocarbon tolerance of R. erythropolis PR4. The strain produced an acidic EPS, mucoidan, together with a fatty acid-containing EPS, PR4 FACEPS. The chemical structure of the mucoidan was determined using (1)H and (13)C NMR spectroscopy and by conducting 2D DQF-COSY, TOCSY, HMQC, HMBC, and NOESY experiments. The mucoidan was shown to consist of a pentasaccharide repeating unit with the following structure: [structure: see text].

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17316584     DOI: 10.1016/j.carres.2007.02.002

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  3 in total

1.  Transcriptome of the quorum-sensing signal-degrading Rhodococcus erythropolis responds differentially to virulent and avirulent Pectobacterium atrosepticum.

Authors:  A Kwasiborski; S Mondy; T-M Chong; C Barbey; K-G Chan; A Beury-Cirou; X Latour; D Faure
Journal:  Heredity (Edinb)       Date:  2015-01-14       Impact factor: 3.821

Review 2.  Fermentation technologies for the optimization of marine microbial exopolysaccharide production.

Authors:  Ilaria Finore; Paola Di Donato; Vincenza Mastascusa; Barbara Nicolaus; Annarita Poli
Journal:  Mar Drugs       Date:  2014-05-22       Impact factor: 5.118

3.  Cholesterol oxidase from Rhodococcus erythropolis with high specificity toward β-cholestanol and pytosterols.

Authors:  Noriyuki Doukyu; Makoto Ishikawa
Journal:  PLoS One       Date:  2020-10-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.